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Of 731 stool specimens collected from children with
diarrhea in Kathmandu, Nepal, from August 2004 through
July 2005, 170 (23.3%) tested positive for rotavirus.
Reverse transcription–PCR, including a revised G12-spe-
cific primer set, identified 56 (32.9%) as G2P[4] and 39
(23.0%) as G12 with P[6], P[8], or P[4].
G
lobally, ≈700,000 children each year die of rotavirus
diarrheal disease, and most such deaths occur in
developing countries (1,2). To reduce this substantial bur-
den of rotavirus diarrhea, 2 live, attenuated oral vaccines
have been licensed in >60 countries and are being intro-
duced into the areas where they are most needed (3). Nepal
is a small, poor, landlocked, subtropical country in Asia
where the severe diarrhea is common. During 2003–2004,
before Nepal was formally integrated into the Asian
Rotavirus Surveillance Network (4), a surveillance study
was initiated, which showed the emergence of G12 strains
against a background of predominant G1P[8] strains (5).
Since the prevalence of G12 strains was unusually high
(20%), and such strains may not be adequately covered by
existing vaccines, there was an urgent need to continue
surveillance and characterization of rotavirus strains by
developing a G12-specific primer pair and to continue to
monitor the prevalence of G12 strains in this population.
The Study
Stool specimens were collected from children with
acute diarrhea attending the rehydration clinic at Kanti
Children’s Hospital, Kathmandu, Nepal, from August 2004
through July 2005. Rotavirus diarrhea was identified by a
commercially available ELISA (Rotaclone, Meridian
Bioscience, Inc., Cincinnati, OH, USA). From the
rotavirus-positive specimens, genomic RNAwas extracted
by using a QIAamp Viral RNA Mini kit (QIAGEN
Sciences, Germantown, MD, USA), and the purified RNA
preparations were used to determine G and P types by
reverse transcription–PCR (RT-PCR) as described by
Uchida et al (5) and by Gouvea et al. (6). For the detection
of G12 strains, a new primer pair was designed based on
the nucleotide sequence of the VP7 gene of strain Arg720
(7). The forward primer, G12F, was 19 mer, corresponding
to nucleotide positions 169–187 (5′-GTT GTT GTC ATG
CTG CCA T-3′), and the reverse primer, G12R, was 20
mer whose sequence was complementary to nucleotide
positions 471–490 (5′-A GTA CAG TAC CAA ATT TCA
T-3′). A G12 strain in the stool specimen was identified by
the presence of a 322-bp band after electroporesis on
agarose gel after PCR typing was done on the first-round
RT-PCR product under the same thermal cycling condi-
tions, including an annealing temperature of 42°C.
Sequencing was performed on the VP7 gene amplification
products with primers Beg9 and End9 (Genomic Research
Center, Shimadzu Corporation, Kyoto, Japan).
Of 731 stool specimens tested by Rotaclone, 170
(23.3%) were positive for rotavirus antigen. When the dis-
tribution of rotavirus-positive cases was examined, 64%
occurred in infants ages 3–23 months, whereas only 2.9%
occurred in infants <3 months of age. Although samples
were not collected in March and April 2005, because of
political instability, rotavirus likely circulated among the
children in Kathmandu throughout the year. However, a
seasonal variation was found in the occurrence of rotavirus
diarrhea with a clear peak in January; the rotavirus detec-
tion rates varied monthly from 7.3% to 58.6%.
Of 170 rotavirus-positive specimens that underwent
molecular genotyping, 4 G and 3 P genotypes were found;
G2 and G12 together accounted for 62% and P[4] and P[6]
together accounted for 74% of their respective genotypes
(Table). Atotal of 10 different G and P genotype combina-
tions were detected, which together accounted for 76% of
rotavirus-positive specimens. Ten (6%) mixed infections,
as defined by the specimens containing more than 1 G or P
genotype, were found, and 31 (18%) specimens remained
untypeable. The most common combinations were G2P[4]
(33%) and G12P[6] (17%). No G4 strains were detected,
nor were any P[9] strains found (which are often associat-
ed with G3 or G12 VP7 specificity). Since neither G3 nor
G9 strains occurred in the preceding season in Kathmandu
(5), their sudden appearance in Nepal needs continued
attention.
The G12 primer pair developed in this study success-
fully amplified 2 established G12 strains, L26 (8) and
Se585 (9), and did not amplify any known G1–G11 and
G13–14 strains (Figure 1). Of 39 stool specimens that were
found to contain G12 rotavirus by the typing reaction with
our G12 primer pair, we selected 12 specimens from those
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product for nucleotide sequencing. Each of these VP7
sequences was identified as G12 because the predicted
amino-acid sequence was 97%–100% identical with that
of prototype G12 strain Se585 in any of antigenic regions
A, B, and C (10). GenBank accession nos. for G12 VP7
genes were AB275291 (05N054), AB275292 (05K021),
AB275293 (05N128), AB275294 (04N605), AB275295
(05N140), AB275296 (05N040), AB275297 (05N065),
AB275298 (05K101), AB275299 (05N138), AB275300
(05K046), AB275301 (05K066), and AB275302
(05N145).
Conclusions
G12 strains, including those in the first human cases
of infection in the Philippines in 1990 (8), had only been
detected in sporadic cases, yet from geographically diverse
locations, including the United States (9), Japan (11),
Brazil (12), South Korea (13), and Thailand (14).
However, recent investigations found that that 17% of
rotaviruses collected from children with acute diarrhea
during 2003–2005 in eastern India and 7.9% of those col-
lected during 1999–2002 in Argentina were of serotype
G12 (7,15). These findings were followed by our previous
study, which showed that 20% of rotaviruses collected dur-
ing 2003–2004 in Nepal were serotype G12 and were
equally distributed between children <15 years of age and
adults (5). The present study (2004–2005) confirms and
extends these observations. Twenty-three percent of
rotaviruses from the same region in the period immediate-
ly following the 2003–2004 study were serotype G12, and
most (76%) were combined with P[6] and others with
either P[8] or P[4], even though the dominant strains
changed from G1P[8] during 2003–2004 (71%) to G2P[4]
during 2004–2005 (33%). The detection of G1P[8]
decreased to a minimum of 5.3% of all rotavirus-positive
strains. The increasing trend of G12 strains in Nepal
appears stable and may reflect the overall trend in the
Ganges region at large, which justifies further surveillance
in Nepal. G12 strains have similarly been detected in mul-
tiple seasons elsewhere. In Brazil, G12 strains continued to
appear during 1999–2002 (7). The emergence and increase
in G12P[6] strains may become a challenge to the current
rotavirus vaccination strategy, the efficacy of which may
depend on the shared G and P serotype specificity of the
vaccine strains and wild-type rotavirus strains circulating
among children. In this context, the detection of a G12
porcine rotavirus strain with a porcine genetic background
in Kolkata, India (16), may indicate reservoirs of an unusu-
al yet emerging G genotype in animals.
The increase in G12 strains also requires the develop-
ment of a rapid detection method by PCR using specific
primers that specifically target G12 strains. Although 2
earlier papers have described similar primers, neither
amplification conditions nor the validation of their speci-
ficity for G12 strains have been described. Since we have
encountered cross-reactions with rotaviruses carrying
other genotypes, i.e, G10, in particular (data not shown),
primers were designed and amplification conditions were
optimized so that no cross-reactions occurred with proto-
type rotavirus strains carrying genotypes G1–11 and
G13–14. This primer pair should become a valuable asset
for the identification of G12 strains found among the non-
typeable specimens in many epidemiologic studies since
the primer binding sites are well conserved among G12
strains from diverse locations (Figure 2).
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Figure 1. Detection after electrophoresis on a 2% agarose gel of
the PCR amplification product with a primer pair G12F and G12R.
The prototype rotavirus strain for each G serotype was as follows;
G1, Wa; G2, KUN; G3, MO; G4, ST3; G5 OSU; G6, NCDV; G7,
PO-13; G8, MW33; G9, 95H115; G10, B223; G11, YM; G12, L26;
G13, L338; and G14, FI23. The first and last lanes show molecu-
lar mass markers in basepairs.This study was supported in part by the United States–Japan
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Figure 2. Comparison of the primer binding regions of the VP7
genes of G12 rotavirus strains detected in various geographic
locations. Primers were designed based on the Arg720 sequence.
The sequence of the forward primer is as shown in the figure; the
sequence of the reverse primer is complementary to that shown in
the figure.